Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

14 Mar 2023 Evaluate
Glenmark Pharmaceuticals has informed that it enclosed press release titled ‘Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP, 75 mg, 150 mg, and 300 mg’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..